M&A Dealmakers Express Hope, Optimism for 2017

The video discusses the general optimism in the market for 2017, driven by expectations of increased dealmaking and potential fiscal stimulus from the US. However, there is caution due to geopolitical uncertainties like Brexit and the US elections. Companies are assessing the impact of these factors on their strategies, with some like J&J reconsidering acquisitions. Despite the challenges, there is hope that economic recovery will boost CEO confidence and lead to more transformational deals.

What was the general sentiment among dealmakers for 2017?

• Optimistic due to increased activity

• Pessimistic due to past challenges

• Concerned about market stability

• Neutral with no clear direction

How did the potential US fiscal stimulus influence corporate strategies?

• It led to a decrease in acquisitions

• It resulted in immediate tax reforms

• It had no impact on corporate decisions

• It encouraged companies to consider tax impacts

Which company was mentioned as attempting a significant acquisition due to tax considerations?

• Merck

• GlaxoSmithKline

• Pfizer

• Johnson & Johnson

What were some of the geopolitical events that contributed to market uncertainty?

• The Paris Agreement

• Brexit and US elections

• The Arab Spring

• The Greek financial crisis

How might economic recovery influence CEO decisions in the coming year?

• It will lead to more conservative strategies

• It will have no effect on decision-making

• It may boost confidence for bold moves

• It will cause a reduction in transformational deals